Carigent Therapeutics

Basic Information

5 Science Park
Suite 13
New Haven, CT, 06511 1966

Company Profile

n/a

Additional Details

Field Value
DUNS: 605510093
Hubzone Owned: Y
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 5


  1. Multimodal Diagnostic and Therapeutic Nanoparticles for Non-Hodgkin's Lymphoma

    Amount: $204,344.00

    DESCRIPTION (provided by applicant): The long-term clinical objective of this proposal Multimodal Diagnostic and Therapeutic Nanoparticles for Non-Hodgkin's Lymphoma is the development of a novel th ...

    SBIR Phase I 2008 Department of Health and Human Services
  2. SBIR PHASE I: Tumor-Targeting Particles for the Delivery of Paclitaxel Against Ovarian Cancer

    Amount: $97,021.00

    PARS Summary This Small Business Innovation Research (SBIR) Phase I research project aims to develop paclitaxel-loaded nano particles with avidin modified surfaces for the targeting of the drug to cel ...

    SBIR Phase I 2008 National Science Foundation
  3. Long Circulating Targeted Nanoparticles for non-Hodgkin's Lymphoma Treatment

    Amount: $153,437.00

    DESCRIPTION (provided by applicant): The long-term objectives of this proposal "Long-Circulating Targeted Nanoparticles for Non-Hodgkin's Lymphoma Treatment" are to (1) develop a novel, surface-modifi ...

    SBIR Phase I 2007 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government